Cepheid

Cepheid is a molecular diagnostics company that develops, manufactures and markets pathogens and genetic testing systems for disease detection. Read more

Warren Kocmond's photo - President of Cepheid

President

Warren Kocmond

CEO Approval Rating

83/100

Founded:

1996

Status:

PrivateSubsidiary of Danaher Corp

Est. Annual Revenue
Est. Employees
Sector

Update Industry

CEPHEID TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

BD is seen as one of Cepheid's top competitors. BD was founded in 1897, and is headquartered in Franklin Lakes, New Jersey. BD operates in the Health Care Equipment industry. BD generates $16.9B more revenue vs. Cepheid.

Illumina is a top competitor of Cepheid. Illumina was founded in 1998, and its headquarters is in San Diego, California. Illumina competes in the Biotechnology industry. Illumina has 5,300 more employees than Cepheid.

Bio-Rad is Cepheid's #3 rival. Bio-Rad was founded in Hercules, California} in 1952. Bio-Rad is in the Health Care Supplies field. Compared to Cepheid, Bio-Rad generates $700.8M more revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $2B a good estimate for Cepheid's revenue?

Cepheid Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Customer Relationships Business, Laboratory Supply Company, Inc.

Oct 2014

Source »
$21M
-

-

Quashnick Tools

Aug 2013

Source »
undisclosed
-

-

Actigenics

Aug 2006

Source »
$1.2M
-

These are all the companies that Cepheid has acquired. Cepheid has acquired 3 companies and its latest acquisition was Customer Relationships Business, Laboratory Supply Company, Inc. in Oct 2014.

Cepheid Funding History

Since Cepheid was founded in 1996, it has participated in 5 rounds of funding. In total Cepheid has raised $32.6M. Cepheid's last funding round was on Aug 2012 for a total of $0

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Angel
Aug 2012
--
IPO
Jun 2000
--

Series C
Jan 2000
$19.1M

Wheatley Partners

Angel
Dec 1997
$11M
Angel
Dec 1996
$2.5M

Since Cepheid was founded in 1996, it has participated in 5 rounds of funding. In total Cepheid has raised $32.6M. Cepheid's last funding round was on Aug 2012 for a total of $0

Cepheid Investments

No recent investments found related to Cepheid

These are all the companies that Cepheid has invested in. Cepheid has invested 3 companies and its latest investment was Customer Relationships Business, Laboratory Supply Company, Inc. in Oct 2014.

Cepheid News

September 29, 2020MarketScreener

Receives Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B and RSV Combination Test

(marketscreener.com) SUNNYVALE, Calif., Sept. 29, 2020 /PRNewswire/ -- Cepheid today announced it has... See more »
July 25, 2020Clinical Lab Products

Rapid Molecular Test for TB Detects Resistance to First-, Second-Line Drugs

FIND and Cepheid are launching the Xpert MTB/XDR test, which enables expanded drug-resistance tubercu... See more »
July 22, 2020Clinical Lab Products

AdvaMed Unveils National Covid-19 Testing Registry

AdvaMed has created a comprehensive, national covid-19 diagnostic supply registry to help state and f... See more »

Cepheid Press Releases

December 28, 2017ForImmediateRelease

Real-time PCR (qPCR) andDigital PCR (dPCR) Market - Expected to Reach $6.3 Billion by 2025

Travel & Tourism Industry release: The global real time PCR (qPCR) and digital PCR (dPCR) market is e... See more »
July 31, 2017Blackbird

Cervical Cancer Diagnostic Testing Devices Market 2017 -Cepheid, Hologic, Qiagen, BD Medical, Arbor Vita, Trovagene, DAAN Gene

Worldwide Cervical Cancer Diagnostic Testing Devices Market 2017 Analysis Report audits a Market Regi... See more »
July 6, 2017MarketersMedia

Global Infectious Disease Diagnostic Market- Becton Dickinson and Company, Cepheid, Inc., Roche Diagnostics

Global Infectious Disease Diagnostic Market is projected to grow with a CAGR between 7.5 % and 8.0% d... See more »
June 8, 2017NewsMaker

SpeeDx and Cepheid Announce European Distribution Partnership

SpeeDx Pty, Ltd., a developer of innovative molecular diagnostic solutions, today announced an agreem... See more »
November 24, 2016NewsMaker

Global Blood Stream Infection Testing Market Grow at a CAGR of 7.75% to 2020

MarketStudyReport.com adds "Global Blood Stream Infection Testing Market 2016-2020" new report to its... See more »

Cepheid Videos

Social Media

Cepheid Headquarters

904 Caribbean Drive

Sunnyvale, California94089

1-888-838-3222

Driving Directions »

Trending Companies

Cepheid Summary

ABOUT

Overview

Cepheid is a molecular diagnostics company that develops, manufactures and markets pathogens and genetic testing systems for disease detection. Cepheid was founded in 1996. Cepheid's headquarters is located in Sunnyvale, California, USA 94089. It has ...

CEO

Cepheid's President, Warren Kocmond, currently has an approval rating of 83%. Cepheid's primary competitors are BD, Illumina & Bio-Rad.

Frequently Asked Questions about Cepheid

  1. When was Cepheid founded?

    Cepheid was founded in 1996
  2. Who is Cepheid's CEO?

    Cepheid's CEO is Warren Kocmond
  3. How much revenue does Cepheid generate?

    Cepheid generates $2B in revenue
  4. How much funding does Cepheid have?

    Cepheid has historically raised $32.6M in funding
  1. Where is Cepheid's headquarters?

    Cepheid's headquarters is in Sunnyvale California, USA
  2. How many employees does Cepheid have?

    Cepheid has 2,500 employees
  3. Who are Cepheid's competitors?

    Cepheid's top competitors are BD, Illumina, Bio-Rad